CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Researchers are looking for new ways to treat people with chronic lymphocytic leukemia (CLL) or small lymphocytic...
Phase 3
Clermont, Florida, United States and 98 other locations
The purpose of this study is to compare the efficacy and safety of pirtobruitinib (LOXO-305) to ibrutinib in participants with CLL/SLL. Participants...
Phase 3
Lakeland, Florida, United States and 179 other locations
Chronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of blood cells). The purpose of this study...
Phase 3
Orange City, Florida, United States and 26 other locations
ALLO-501A in adults with relapsed or refractory large B-cell lymphoma and assess the safety of ALLO-501A in adults with relapsed or refractory chronic...
Phase 1, Phase 2
Orlando, Florida, United States and 38 other locations
This is an open-label, multi-center Phase 1/2 study of oral LOXO-305 (pirtobrutinib) in patients with CLL/SLL and NHL who have failed or are intolera...
Phase 1, Phase 2
Lake Mary, Florida, United States and 55 other locations
This study is a first-in-human, Phase 1a/1b, multicenter, open-label study to determine the safety, tolerability, and pharmacokinetics of aplitabart...
Phase 1
Lake Mary, Florida, United States and 57 other locations
This study is being done to evaluate the safety, tolerability and effectiveness of Oral CG-806 for the treatment of patients with chronic ly ...
Phase 1
Orlando, Florida, United States and 29 other locations
The primary objective of this study is to evaluate the safety of zanubrutinib (also known as BGB-3111) in chronic lymphocytic leukemia...
Phase 2
Orange City, Florida, United States and 34 other locations
Clinical trials
Research sites
Resources
Legal